Anadys completes direct public offering

Anadys Pharmaceuticals Inc. (NASDAQ:ANDS), San Diego, Calif. Business: Infectious, Cancer Date completed: 6/4/09 Type: Direct public offering Raised: $17.5 million Units: 8.4 million Price: $2.09 (uni...